<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE paragraph
  PUBLIC "-//IFRS//DTD DITA Paragraph//EN" "../../../../DocTypes/com.ifrs.doctype/dtd/paragraph.dtd">
<paragraph base="IAS2020-2" id="IAS16_BC16A"><paranum>BC16A</paranum><prolog><data name="standard_number" value="IAS 16"/><data name="paranum" value="BC16A"/></prolog><body><p>Before the 2020 amendments, paragraph 17(e) specified that directly attributable costs       included the costs of testing whether an asset was functioning properly, after deducting the       net proceeds from selling items produced while bringing the asset to the location and       condition necessary for it to be capable of operating in the manner intended by management.       The Board received a request asking whether:</p><ol type="lower-alpha"><li><li_value>(a)</li_value><p>the proceeds specified in paragraph 17(e) related only to items           produced while testing; and</p></li><li><li_value>(b)</li_value><p>an entity was required to deduct from the cost of an item of           property, plant and equipment any such proceeds that exceeded the costs of testing.</p></li></ol></body></paragraph>